Vasculitis UK runs a helpline that has helps point users to advice and resources that can make an enormous difference, especially to those newly diagnosed. The helpline is staffed by …
AGM 2025
Vasculitis UK will be holding its 2025 AGM on Sunday 18 May. In contrast to recent years, this will be in-person event only: it will not be recorded. The event …
Volunteer Roles at VUK
Vasculitis UK is looking for volunteers to strengthen its team – you may be that person! We’re seeking enthusiastic volunteers to help in three areas. (Click the links to see …
Impact of reported misdiagnoses
‘I still can’t forget those words’: mixed methods study of the persisting impact on patients reporting psychosomatic and psychiatric misdiagnoses
Blood protein profiles provide new insights into large-vessel vasculitis
Large-vessel vasculitis (LVV) is the name for a group of diseases that cause inflammation and damage to arteries (the blood vessels that carry blood away from the heart). LVV affects …
MELODY study: Boosters reduce Covid problems for those with weakened immunity
The MELODY study by Imperial College and Nottingham University and part-funded by Vasculitis UK, has looked at COVID-19 antibodies, infection and hospitalisation in three immunosuppressed groups, including people with RAIRDs. …
Imagery techniques for people living with vasculitis
A research project, funded by Vasculitis UK and run by the RECORDER team at the University of Nottingham, has created an imagery wellbeing programme. More details here.
Autumn COVID and Flu Vaccine 2024 eligibility
Who should have the flu and COVID-19 vaccines You can get both the NHS flu and COVID-19 vaccines if you: Other care home residents, carers and people who live with …
Covid Boosters
Spring COVID Vaccine 2024 booster eligibility The government has announced a Spring 2024 dose of COVID-19 vaccine for: Those eligible should be offered an appointment between April and June by …
VAS-UP: study on steroid toxicity
VAS-UP: “UPgrading multilevel methods of assessing toxicity from steroids in VASculitis and other related conditions“ The researchers would welcome your participation in phase 1b of this Oxford University study. They are …
